Product Code: ETC340825 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The pneumonia vaccine market in Thailand is a critical component of the country`s public health efforts to prevent and control respiratory infections. Pneumonia is a significant cause of morbidity and mortality, particularly among vulnerable populations, such as the elderly and young children. Thailand healthcare system places importance on vaccination programs, and pneumonia vaccines are administered as part of routine immunization schedules. The market includes various vaccine formulations designed to protect against different pneumonia-causing pathogens. Access to vaccines and vaccination coverage rates are central to the market`s dynamics, with government initiatives and public awareness campaigns playing a pivotal role in reducing the burden of pneumonia.
The Thailand pneumonia vaccine market is experiencing growth primarily due to the government`s focus on improving healthcare infrastructure and vaccination programs. Thailand has a growing elderly population, and pneumonia is a significant health concern among the elderly. This demographic shift is driving the demand for pneumonia vaccines. Moreover, increasing awareness of the importance of preventive healthcare and vaccination, coupled with rising healthcare expenditure, has resulted in a higher vaccination rate in the country. Additionally, the COVID-19 pandemic has underscored the importance of vaccines, leading to a broader acceptance of vaccination in the Thai society. Collaborations between pharmaceutical companies and government healthcare agencies to enhance vaccine distribution and accessibility are also contributing to market growth. Furthermore, efforts to combat antibiotic resistance, as well as increasing air pollution in urban areas, have heightened the urgency to prevent respiratory illnesses like pneumonia, boosting the market further.
In the Thailand pneumonia vaccine market, accessibility and affordability remain significant challenges. Ensuring that vaccines are available and affordable to a broad segment of the population is crucial for effective disease prevention. Public awareness and vaccination coverage also play a pivotal role in overcoming challenges related to vaccine hesitancy. Additionally, the constant evolution of pneumonia-causing pathogens requires vaccine developers to stay ahead in research and development efforts.
The COVID-19 pandemic brought increased attention to vaccines, including those for pneumonia. While resources and focus were redirected towards COVID-19 vaccines, routine immunization programs for pneumonia faced disruptions. Healthcare systems were overwhelmed, affecting vaccine distribution and administration. However, the pandemic also underscored the importance of vaccines, potentially driving future investments in vaccination programs and research.
The Thailand pneumonia vaccine market features global pharmaceutical companies such as Pfizer Inc. and GlaxoSmithKline (GSK) who provide pneumonia vaccines to help prevent this respiratory disease.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Pneumonia Vaccine Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Pneumonia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Pneumonia Vaccine Market - Industry Life Cycle |
3.4 Thailand Pneumonia Vaccine Market - Porter's Five Forces |
3.5 Thailand Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Thailand Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Thailand Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2021 & 2031F |
3.8 Thailand Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Pneumonia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Thailand |
4.2.2 Growing government initiatives to promote vaccination programs |
4.2.3 Rising prevalence of pneumonia cases in Thailand |
4.3 Market Restraints |
4.3.1 High cost of pneumonia vaccines |
4.3.2 Limited access to healthcare services in remote areas of Thailand |
4.3.3 Presence of alternative treatment options for pneumonia |
5 Thailand Pneumonia Vaccine Market Trends |
6 Thailand Pneumonia Vaccine Market, By Types |
6.1 Thailand Pneumonia Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Pneumonia Vaccine Market Revenues & Volume, By Vaccine Type, 2021-2031F |
6.1.3 Thailand Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021-2031F |
6.1.4 Thailand Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021-2031F |
6.2 Thailand Pneumonia Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Thailand Pneumonia Vaccine Market Revenues & Volume, By Prevnar 13, 2021-2031F |
6.2.3 Thailand Pneumonia Vaccine Market Revenues & Volume, By Synflorix, 2021-2031F |
6.2.4 Thailand Pneumonia Vaccine Market Revenues & Volume, By Pneumovax 23, 2021-2031F |
6.3 Thailand Pneumonia Vaccine Market, By Sector |
6.3.1 Overview and Analysis |
6.3.2 Thailand Pneumonia Vaccine Market Revenues & Volume, By Public, 2021-2031F |
6.3.3 Thailand Pneumonia Vaccine Market Revenues & Volume, By Private, 2021-2031F |
6.4 Thailand Pneumonia Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Thailand Pneumonia Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021-2031F |
6.4.3 Thailand Pneumonia Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021-2031F |
6.4.4 Thailand Pneumonia Vaccine Market Revenues & Volume, By Government Authorities, 2021-2031F |
7 Thailand Pneumonia Vaccine Market Import-Export Trade Statistics |
7.1 Thailand Pneumonia Vaccine Market Export to Major Countries |
7.2 Thailand Pneumonia Vaccine Market Imports from Major Countries |
8 Thailand Pneumonia Vaccine Market Key Performance Indicators |
8.1 Immunization coverage rate for pneumonia vaccines in Thailand |
8.2 Number of government-funded vaccination campaigns conducted annually |
8.3 Percentage increase in demand for pneumonia vaccines in Thailand |
8.4 Average waiting time for receiving pneumonia vaccination in healthcare facilities |
8.5 Number of reported pneumonia cases in Thailand |
9 Thailand Pneumonia Vaccine Market - Opportunity Assessment |
9.1 Thailand Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Thailand Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Thailand Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2021 & 2031F |
9.4 Thailand Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Pneumonia Vaccine Market - Competitive Landscape |
10.1 Thailand Pneumonia Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Thailand Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |